Equity Analysis /
United States of America

US : ADMA Biologics, Inc. - ADMA | 4Q21 Results: Takin' Care of Business; Sales Momentum Builds & New Debt Bridges to Break-Even

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    26 March 2022
    Published by